TITLE:
Comparative Costs of Different Renal Replacement Therapies in Lower Middle Income Countries on the Example of Georgia
AUTHORS:
Avtandil Tataradze, George Managadze, Lela Beglarashvili, Nikoloz Kipshidze, Laurent Managadze, Archil Chkhotua
KEYWORDS:
End-Stage Renal Disease (ESRD), Renal Replacement Therapy (RRT) Costs, Hemodialysis, Peritoneal Dialysis, Kidney Transplantation (KT)
JOURNAL NAME:
International Journal of Clinical Medicine,
Vol.7 No.7,
July
5,
2016
ABSTRACT: End-Stage Renal Disease (ESRD) represents one of the most challenging social and medical problems mainly due to substantial treatment-associated costs. The chronic nature of the disease needs expensive continuous care that majority of the patients cannot afford. Therefore, in many countries expenses associated with the ESRD treatment is paid by state government. These treatment options include: hemodialysis, peritoneal dialysis and kidney transplantation. Multiple studies have been conducted throughout the world to assess cost-effectiveness of these treatment modalities. The studies suggest that kidney transplantation not only reduces mortality and morbidity but improves a quality of life of ESRD patients. Furthermore, it is the most cost-effective treatment for the ESRD at least in high-income countries. The goal of our study was to determine whether above-mentioned is true for lower middle income countries, where the cost of the ESRD treatment is substantially lower. Despite the low dialysis costs, transplantation remains the cheapest form of renal replacement therapy RRT in lower income countries like Georgia. Our results reveal, that kidney transplantation is most expensive modality of Renal Replacement Therapy (RRT) at month 1, but count of costs reveals that after the 10th month of treatment, the cumulative cost of transplantation is less than the cumulative cost of peritoneal dialysis and after the 23rd month, cumulative cost of hemodialysis also surpasses the cumulative cost of transplantation-related treatment and this cost comparison is in line with global data from upper-middle and high income countries.